In a regulatory filing, Treace Medical (TMCI) disclosed that its CEO John Treace bought 60K shares of common stock on March 4th in a total transaction size of $524K. Shares of Treace Medical are up 4% afterhours at $9.20.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI: